No matches

18 search results for: Chronic Spontaneous Urticaria

Diagnosing CSU: Hives, Angioedema, and Differential Diagnosis
Dermatology
Diagnosing CSU: Hives, Angioedema, and Differential Diagnosis
expert video

Dr. Elena Netchiporouk illustrates key considerations for diagnosing CSU at EADV 2025.

View more
Heterogeneity and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU
Dermatology
Heterogeneity and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU
expert video

In this video from EADV 2025, Dr. Netchiporouk discusses the clinical features, diagnosis, and burden of CSU

View more
Immunological Drivers in CSU: Diverse Pathways to Mast Cell Activation
Dermatology
Immunological Drivers in CSU: Diverse Pathways to Mast Cell Activation
expert video

In this video from EADV 2025, Dr. Hawkes reviews the pathophysioogy of CSU with a focus on the role of type 2 inflammation

View more
Expert Interview with Dr Jason Hawkes
Dermatology
Expert Interview with Dr Jason Hawkes
expert video

Join Dr. Hawkes as he discusses what burdens and challenges CSU patients might expect and help identify that there are immune functions responsible for their symptoms not an external cause.

View more
The Clinical Presentation of CSU is Heterogeneous
Dermatology
The Clinical Presentation of CSU is Heterogeneous
expert video

Dr Hawkes provides an overview of the distinctive characteristics of wheals and angioedema in clinical manifestation

View more
Potential Role of Type 2 Inflammation in the Pathogenesis of CSU
Dermatology
Potential Role of Type 2 Inflammation in the Pathogenesis of CSU
expert video

Join Professor Hide as he describes the potential role of Type 2 inflammation in the pathogenesis of CSU.

View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: EstoniaChange country/region